Amy M Fulton Selected Research

Prostaglandin E Receptors (Prostaglandin E Receptor)

1/2017	Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer.
1/2013	A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis.
4/2012	Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2.
10/2010	Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities.
9/2009	Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function.
10/2006	Targeting prostaglandin E EP receptors to inhibit metastasis.
3/2006	Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amy M Fulton Research Topics

Disease

23	Neoplasms (Cancer) 01/2021 - 04/2002
19	Breast Neoplasms (Breast Cancer) 01/2017 - 04/2002
17	Neoplasm Metastasis (Metastasis) 01/2017 - 11/2002
2	Triple Negative Breast Neoplasms 01/2017 - 01/2016
1	Ductal Carcinoma 01/2015
1	Inflammation (Inflammations) 03/2009
1	Carcinoma (Carcinomatosis) 05/2007
1	Lymphatic Metastasis 01/2004

Drug/Important Bio-Agent (IBA)

10	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020 - 03/2006
7	Dinoprostone (PGE2)FDA Link 01/2020 - 05/2007
7	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 01/2017 - 03/2006
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2002
5	CytokinesIBA 01/2020 - 05/2002
5	ProstaglandinsIBA 01/2017 - 10/2006
4	Chemokine ReceptorsIBA 01/2015 - 01/2004
3	EnzymesIBA 01/2020 - 01/2004
3	15-hydroxyprostaglandin dehydrogenaseIBA 01/2017 - 01/2015
3	Protein Isoforms (Isoforms)IBA 01/2015 - 04/2002
3	ChemokinesIBA 03/2009 - 01/2004
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2007 - 04/2002
3	Celecoxib (Celebrex)FDA Link 10/2005 - 04/2002
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2005 - 04/2002
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2013 - 03/2009
2	Prostaglandins EIBA 04/2012 - 03/2006
2	frondoside AIBA 04/2012 - 02/2012
2	Small Interfering RNA (siRNA)IBA 10/2010 - 09/2009
2	AH 23848IBA 09/2009 - 03/2006
2	Chemotactic FactorsIBA 07/2007 - 05/2002
2	LigandsIBA 10/2005 - 01/2004
2	CXC ChemokinesIBA 01/2004 - 05/2002
2	SC 560IBA 11/2002 - 04/2002
1	TESIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	EicosanoidsIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 02/2016
1	Oxidoreductases (Dehydrogenase)IBA 01/2016
1	LipidsIBA 01/2015
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2012
1	InterferonsIBA 02/2012
1	Estrogen ReceptorsIBA 02/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2012
1	6-isopropoxy-9-oxoxanthene-2-carboxylic acidIBA 10/2010
1	Messenger RNA (mRNA)IBA 10/2010
1	Interferon-gamma (Interferon, gamma)IBA 09/2009
1	Biomarkers (Surrogate Marker)IBA 03/2009
1	Chemokine CXCL9IBA 07/2007
1	4- (5- (4- chlorophenyl)- 3- (trifluoromethyl)- 1H- pyrazol- 1- yl)benzenesulfonamideIBA 05/2007
1	Interleukin-1beta (Interleukin 1 beta)IBA 05/2007
1	Hormones (Hormone)IBA 10/2006
1	N- (1- (3- (4- ethoxyphenyl)- 4- oxo- 3,4- dihydropyrido(2,3- d)pyrimidin- 2- yl)ethyl)- N- pyridin- 3- ylmethyl- 2- (4- trifluoromethoxyphenyl)acetamideIBA 08/2006
1	4- (4- cyano- 2- (2- (4- fluoronaphthalen- 1- yl)propionylamino)phenyl)butyric acidIBA 03/2006
1	Histocompatibility Antigens Class IIBA 10/2005
1	Indomethacin (Indometacin)FDA LinkGeneric 10/2005
1	Therapeutic UsesIBA 10/2005
1	hydrogen sulfite (bisulfite)IBA 01/2004
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2004
1	Cyclooxygenase 1IBA 11/2002
1	AntibodiesIBA 05/2002
1	Complementary DNA (cDNA)IBA 05/2002
1	Interleukin-10 (Interleukin 10)IBA 05/2002
1	InterleukinsIBA 05/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2004
2	Immunotherapy 01/2020 - 07/2007
2	Oral Administration 01/2013 - 04/2002
2	Transplantation 01/2004 - 05/2002
1	Drug Therapy (Chemotherapy) 01/2020